Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23521100 | 0.86 | SOS1 (0.57) | SOS1KRAS | |
| SCHEMBL29002528 | 0.86 | SOS1 (0.57) | SOS1KRAS | |
| SCHEMBL30148552 | 0.86 | SOS1 (0.57) | SOS1KRAS | |
| SCHEMBL23412405 | 0.85 | SOS1 (0.45) | SOS1KRAS | |
| SCHEMBL23412403 | 0.85 | SOS1 (0.45) | SOS1KRAS | |
| SCHEMBL29723197 | 0.85 | SOS1 (0.45) | SOS1KRAS | |
| SCHEMBL23520597 | 0.83 | SOS1 (0.65) | SOS1KRAS | |
| SCHEMBL23520739 | 0.83 | SOS1 (0.51) | SOS1KRAS | |
| SCHEMBL31115549 | 0.83 | SOS1 (0.44) | SOS1KRAS | |
| SCHEMBL23520604 | 0.80 | SOS1 (0.51) | SOS1KRAS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210177851-A1 | NOVEL BENZYLAMINO SUBSTITUTED QUINAZOLINES AND DERIVATIVES AS SOS1 INHIBITORS | BOEHRINGER INGELHEIM INT (DE) | 2021-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210177851-A1 | NOVEL BENZYLAMINO SUBSTITUTED QUINAZOLINES AND DERIVATIVES AS SOS1 INHIBITORS | SOS1, SOS2, SOST | SOS1 1/4885KRAS 20/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.